Predictors of health-related quality of life and adjustment to prostate cancer during active surveillance

European Urology

Volumn 64, Issue 1, 2013, Pages 30-36

  Bellardita, Lara ^a   Rancati, Tiziana ^a   Alvisi, Maria Francesca ^a   Villani, Daniela ^b   Magnani, Tiziana ^a   Marenghi, Cristina ^a   Nicolai, Nicola ^a   Procopio, Giuseppe ^a   Villa, Sergio ^a   Salvioni, Roberto ^a   Valdagni, Riccardo ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

Author keywords

Active surveillance; Adjustment to cancer; Coping; Prostate cancer; Quality of life

Indexed keywords

ADJUSTMENT; ADULT; AGED; ARTICLE; DISEASE SURVEILLANCE; FOLLOW UP; HUMAN; HYPOTHESIS; INTERNATIONAL PROSTATE SYMPTOM SCORE; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; RISK ASSESSMENT; SYMPTOM CHECKLIST 90;

ADAPTATION, PSYCHOLOGICAL; AGED; BIOPSY; COST OF ILLNESS; HUMANS; LOGISTIC MODELS; MALE; MARITAL STATUS; MENTAL HEALTH; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; SOCIAL SUPPORT; STRESS, PSYCHOLOGICAL; TIME FACTORS; WATCHFUL WAITING;

EID: 84878828115     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.01.009     Document Type: Article

References (30)

1. M.M. Center, A. Jemal, and J. Lortet-Tieulent International variation in prostate cancer incidence and mortality rates Eur Urol 61 2012 1079 1092
2. A.J. Vickers, M.J. Roobol, and H. Lilja Screening for prostate cancer: early detection or overdetection? Ann Rev Med 63 2011 161 170
3. A. Heidenreich, J. Bellmunt, and M. Bolla EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease Eur Urol 59 2011 61 71
4. J. Mohler, R.R. Bahnson, and B. Boston NCNN clinical practice guidelines in oncology: prostate cancer J Natl Compr Canc Netw 8 2010 162 200
5. M.R. Cooperberg, P.R. Carroll, and L. Klotz Active surveillance for prostate cancer: progress and promise J Clin Oncol 29 2011 3669 3676
6. L. Klotz Active surveillance for favorable-risk prostate cancer: background, patient selection, triggers for intervention, and outcomes Curr Urol Rep 13 2012 153 159
7. J. Xia, B.J. Trock, M.R. Cooperberg, and R. Gulati Prostate cancer mortality following active surveillance versus immediate radical prostatectomy Clin Cancer Res 18 2012 5471 5478
8. G.J. Huang, N. Sadetsky, and D.F. Penson Health related quality of life for men treated for localized prostate cancer with long-term followup J Urol 183 2010 2206 2212
9. K.L. Burnet, C. Parker, D. Dearnaley, C.R. Brewin, and M. Watson Does active surveillance for men with localized prostate cancer carry psychological morbidity? BJU Int 100 2007 540 543
10. R.C. Van den Bergh, M.L. Essink-Bot, M.J. Roobol, F.H. Schroder, C.H. Bangma, and E.W. Steyerberg Do anxiety and distress increase during active surveillance for low risk prostate cancer? J Urol 183 2010 1786 1791
11. R.C. Van den Bergh, I.J. Korfage, and C.H. Bangma Psychological aspects of active surveillance Curr Opin Urol 22 2012 237 242
12. H. Vasarainen, U. Lokman, M. Ruutu, K. Taari, and A. Rannikko Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial BJU Int 109 2012 1614 1619
13. D.M. Latini, S.L. Hart, and S.J. Knight The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance J Urol 178 2007 826 831
14. L. Bellardita, G. Graffigna, and S. Donegani Patient's choice of observational strategy for early-stage prostate cancer Neuropsychological Trends 12 2012 107 116
15. L.R. Derogatis SCL-90-R: administration, scoring, and procedures manual ed. 3. 1994 National Computer Systems Minneapolis, MN
16. E.L. Lev, L.S. Eller, and G. Gejerman Quality of life of men treated with brachytherapies for prostate cancer Health Qual Life Outcomes 2 2004 28
17. J.L. Bosch, W.C. Hop, W.J. Kirkels, and F.H. Schröder The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume Br J Urol 75 1995 622 630
18. R.C. Rosen, A. Riley, G. Wagner, I.H. Osterloh, J. Kirkpatrick, and A. Mishra The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction Urology 49 1997 822 830
19. D. Cella, M.B. Nichol, D. Eton, J.B. Nelson, and P. Mulani Estimating clinically meaningful changes for the Functional Assessment of Cancer Therapy - Prostate: results from a clinical trial of patients with metastatic hormone-refractory prostate cancer Value Health 12 2009 124 129
20. W.R. Lee, M.C. Hall, R.P. McQuellon, L.D. Case, and D.L. McCullough A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy Int J Radiat Oncol Biol Phys 51 2001 614 623
21. S. Greer, and M. Watson Mental adjustment to cancer: its measurement and prognostic importance Cancer Surv 6 1987 439 453
22. G.C. Barnett, C.M. West, and C.E. Coles Standardized Total Average Toxicity Score: a scale- and grade-independent measure of late radiotherapy toxicity to facilitate pooling of data from different studies Int J Radiat Oncol Biol Phys 82 2012 1065 1074
23. M.A. Dall'Era, P.C. Albertsen, and C. Bangma Active surveillance for prostate cancer: a systematic review of the literature Eur Urol 62 2012 976 983
24. M. Johansson, A. Rydén, and C. Finizia Mental adjustment to cancer and its relation to anxiety, depression, HRQL and survival in patients with laryngeal cancer - a longitudinal study BMC Cancer 11 2011 283
25. C. Segrin, T.A. Badger, and J. Harrington Interdependent psychological quality of life in dyads adjusting to prostate cancer Health Psychol 31 2012 70 79
26. I.J. Korfage, M.L. Essink-Bot, A.C. Janssens, F.H. Schröder, and H.J. de Koning Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up Br J Cancer 94 2006 1093 1098
27. R.C. Van den Bergh, H.A. van Vugt, and I.J. Korfage Disease insight and treatment perception of men on active surveillance for early prostate cancer BJU Int 105 2010 322 328
28. M.A. Gorin, C.T. Soloway, A. Eldefrawy, and M.S. Soloway Factors that influence patient enrollment in active surveillance for low-risk prostate cancer Urology 77 2011 588 591
29. R.C. Van den Bergh, M.L. Essink-Bot, and M.J. Roobol Anxiety and distress during active surveillance for early prostate cancer Cancer 115 2009 3868 3878
30. Bellardita L, Rancati T, Villani D, et al. Predictors of poor quality of life in patients in active surveillance. Poster presented at: the 27th Annual Congress of the European Association of Urology; February 2012; Paris, France.